- Home
- CMPO vs IDYA Comparison
CMPO vs IDYA Comparison
Compare CMPO & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPO
- IDYA
- Stock Information
- Founded
- CMPO 2000
- IDYA 2015
- Country
- CMPO United States
- IDYA United States
- Employees
- CMPO N/A
- IDYA N/A
- Industry
- CMPO Finance: Consumer Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- CMPO Finance
- IDYA Health Care
- Exchange
- CMPO Nasdaq
- IDYA Nasdaq
- Market Cap
- CMPO 2.1B
- IDYA 2.3B
- IPO Year
- CMPO N/A
- IDYA 2019
- Fundamental
- Price
- CMPO $19.79
- IDYA $29.27
- Analyst Decision
- CMPO Strong Buy
- IDYA Buy
- Analyst Count
- CMPO 6
- IDYA 17
- Target Price
- CMPO $18.83
- IDYA $47.87
- AVG Volume (30 Days)
- CMPO 663.6K
- IDYA 1.4M
- Earning Date
- CMPO 11-07-2025
- IDYA 11-04-2025
- Dividend Yield
- CMPO N/A
- IDYA N/A
- EPS Growth
- CMPO N/A
- IDYA N/A
- EPS
- CMPO N/A
- IDYA N/A
- Revenue
- CMPO $267,817,999.00
- IDYA $7,000,000.00
- Revenue This Year
- CMPO $10.30
- IDYA $261.10
- Revenue Next Year
- CMPO $8.12
- IDYA $77.77
- P/E Ratio
- CMPO N/A
- IDYA N/A
- Revenue Growth
- CMPO N/A
- IDYA N/A
- 52 Week Low
- CMPO $9.24
- IDYA $13.45
- 52 Week High
- CMPO $21.00
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- CMPO 50.15
- IDYA 62.67
- Support Level
- CMPO $19.06
- IDYA $26.89
- Resistance Level
- CMPO $20.89
- IDYA $31.07
- Average True Range (ATR)
- CMPO 0.69
- IDYA 1.46
- MACD
- CMPO -0.15
- IDYA 0.21
- Stochastic Oscillator
- CMPO 39.85
- IDYA 64.14
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.